BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30848985)

  • 1. Role of Serum miR-181b, Proinflammatory Cytokine, and Adhesion Molecules in Behçet's Disease.
    El Boghdady NA; Shaker OG
    J Interferon Cytokine Res; 2019 Jun; 39(6):347-354. PubMed ID: 30848985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's disease.
    Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Hernandez MV; Espinosa G; Adán A
    Mediators Inflamm; 2014; 2014():396204. PubMed ID: 24994946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
    Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
    J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
    Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
    Front Immunol; 2021; 12():724900. PubMed ID: 35003055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
    Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of resistin in Behçet's disease: a Turkish experiment.
    Pehlivan Y; Onat AM; Okumuş S; Kisacik B; Comez G; Comez A; Goktepe F; Ceylan NO
    Mod Rheumatol; 2012 Aug; 22(4):571-5. PubMed ID: 22038316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease.
    Kosar A; Haznedaroglu S; Karaaslan Y; Büyükasik Y; Haznedaroglu IC; Ozath D; Sayinalp N; Ozcebe O; Kirazli S; Dündar S
    Rheumatol Int; 1999; 19(1-2):11-4. PubMed ID: 10651074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-α and CTLA4 genes in patients with Behcet's disease.
    Kolahi S; Farajzadeh MJ; Alipour S; Abhari A; Farhadi J; Bahavarnia N; Malek Mahdavi A; Khabbazi A; Sakhinia E
    Immunol Lett; 2018 Dec; 204():55-59. PubMed ID: 30366049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
    Çerçi P; Altıner S; İnal A; Köse K; Keskin G; Ölmez Ü
    Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
    Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
    Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Cytokine Levels in Behçet's Disease.
    Akkurt ZM; Bozkurt M; Uçmak D; Yüksel H; Uçak H; Sula B; Gürsel Özkurt Z; Yildiz M; Akdeniz D; Arica M
    J Clin Lab Anal; 2015 Jul; 29(4):317-20. PubMed ID: 25130392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease.
    Adam B; Calikoglu E
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):318-20. PubMed ID: 15096143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
    Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
    Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature.
    Kötter I; Koch S; Vonthein R; Rückwaldt U; Amberger M; Günaydin I; Zierhut M; Stübiger N
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S20-6. PubMed ID: 16273760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-181b Serves as a Circulating Biomarker and Regulates Inflammation in Heart Failure.
    Yang H; Shan L; Gao Y; Li L; Xu G; Wang B; Yin X; Gao C; Liu J; Yang W
    Dis Markers; 2021; 2021():4572282. PubMed ID: 34306253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.